Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer |
Kang, Ki Mun
(Department of Radiation Oncology, Gyeongsang National University School of Medicine)
Jeong, Bae Kwon (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Ha, In Bong (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Chai, Gyu Young (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Lee, Gyeong Won (Institute of Health Science, Gyeongsang National University School of Medicine) Kim, Hoon Gu (Institute of Health Science, Gyeongsang National University School of Medicine) Kang, Jung Hoon (Institute of Health Science, Gyeongsang National University School of Medicine) Lee, Won Seob (Institute of Health Science, Gyeongsang National University School of Medicine) Kang, Myoung Hee (Institute of Health Science, Gyeongsang National University School of Medicine) |
1 | Gridelli C, Perrone F, Monfardini S. Lung cancer in the elderly. Eur J Cancer 1997;33:2313-4. DOI ScienceOn |
2 | Havlik RJ, Yancik R, Long S, Ries L, Edwards B. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994;74:2101-6. DOI ScienceOn |
3 | Gridelli C, Massarelli E, Maione P, et al. Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly. Cancer 2004; 101:1733-44. DOI ScienceOn |
4 | Casas F, Kepka L, Agarwal JP, et al. Radiochemotherapy in the elderly with lung cancer. Expert Rev Anticancer Ther 2009;9:1405-11. DOI ScienceOn |
5 | Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004;22:4626-31. DOI ScienceOn |
6 | Curran WJ Jr, Paulus R, Langer CJ, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011;103:1452-60. DOI ScienceOn |
7 | Zatloukal P, Petruzelka L, Zemanova M, et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 2004;46:87-98. DOI ScienceOn |
8 | Gridelli C, Maione P, Rossi A, et al. Treatment of advanced non-small-cell lung cancer in the elderly. Lung Cancer 2009;66:282-6. DOI ScienceOn |
9 | Atagi S, Kawahara M, Yokoyama A, et al. Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301). Lancet Oncol 2012;13:671-8. DOI ScienceOn |
10 | Lau DH, Crowley JJ, Gandara DR, et al. Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer. J Clin Oncol 1998;16:3078-81. DOI |
11 | Davidoff AJ, Gardner JF, Seal B, Edelman MJ. Populationbased estimates of survival benefi t associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer. J Thorac Oncol 2011;6:934-41. DOI ScienceOn |
12 | Kang KM, Lee GW, Kim HG, Kang JH, Lee WS, Chai GY. Paclitaxel and cisplatin with induction chemotherapy followed by concurrent chemoradiotherapy for stage IIIB non-small cell lung cancer. J Korean Soc Ther Radiol Oncol 2006;24:223-9. |
13 | Hayakawa K, Mitsuhashi N, Katano S, et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 2001;32:81-8. DOI ScienceOn |
14 | Movsas B, Scott C, Sause W, et al. The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. Int J Radiat Oncol Biol Phys 1999;45:1143-9. DOI ScienceOn |
15 | Werner-Wasik M, Scott C, Cox JD, et al. Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival. Int J Radiat Oncol Biol Phys 2000;48:1475-82. DOI ScienceOn |
16 | Schild SE, Stella PJ, Geyer SM, et al. The outcome of combinedmodality therapy for stage III non-small-cell lung cancer in the elderly. J Clin Oncol 2003;21:3201-6. DOI ScienceOn |
![]() |